Literature DB >> 28589405

Drug-Coated Balloon Angioplasty: A Novel Treatment for Pulmonary Artery In-Stent Stenosis in a Patient with Williams Syndrome.

Jennifer L Cohen1, Julie S Glickstein2, Matthew A Crystal2.   

Abstract

A 20-month-old boy with Williams syndrome had undergone multiple surgical and catheter-based interventions for resistant peripheral pulmonary arterial stenoses with eventual bilateral stent placement and conventional balloon angioplasty. He persistently developed suprasystemic right ventricular (RV) pressure. Angioplasty with a drug-coated balloon (DCB) was performed for in-stent restenosis and to remodel his distal pulmonary vessels bilaterally. This resulted in immediate improvement in the in-stent stenosis and resultant decrease in RV pressure. Follow-up catheterization two months later continued to show long-lasting improvement in the in-stent stenosis. We hypothesize that the anti-proliferative effects of DCBs may be of benefit in the arteriopathy associated with Williams syndrome. We report this as a novel use of a DCB in the pulmonary arterial circulation in a patient with Williams syndrome.

Entities:  

Keywords:  Drug-coated balloon; Intravascular ultrasound; Peripheral pulmonic stenosis; Williams syndrome

Mesh:

Year:  2017        PMID: 28589405     DOI: 10.1007/s00246-017-1646-1

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  14 in total

1.  Restenosis and pseudoaneurysm formation after stent placement for aortic coarctation in Williams syndrome.

Authors:  Sotiria C Apostolopoulou; Nikolaos L Kelekis; Cleo Laskari; Loukas Kaklamanis; Spyridon Rammos
Journal:  J Vasc Interv Radiol       Date:  2002-05       Impact factor: 3.464

2.  Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter.

Authors:  Bruno Scheller; Christoph Hehrlein; Wolfgang Bocksch; Wolfgang Rutsch; Dariush Haghi; Ulrich Dietz; Michael Böhm; Ulrich Speck
Journal:  N Engl J Med       Date:  2006-11-13       Impact factor: 91.245

3.  Endoarterial scoring--a novel treatment for resistant pulmonary arterial lesions associated with Williams-Beuren syndrome.

Authors:  Laisha Gogola; Gruschen R Veldtman
Journal:  J Invasive Cardiol       Date:  2010-04       Impact factor: 2.022

4.  Long-Term Safety of Drug-Eluting and Bare-Metal Stents: Evidence From a Comprehensive Network Meta-Analysis.

Authors:  Tullio Palmerini; Umberto Benedetto; Giuseppe Biondi-Zoccai; Diego Della Riva; Letizia Bacchi-Reggiani; Pieter C Smits; Georgios J Vlachojannis; Lisette Okkels Jensen; Evald H Christiansen; Klára Berencsi; Marco Valgimigli; Carlotta Orlandi; Mario Petrou; Claudio Rapezzi; Gregg W Stone
Journal:  J Am Coll Cardiol       Date:  2015-06-16       Impact factor: 24.094

5.  Balloon dilation angioplasty of peripheral pulmonary stenosis associated with Williams syndrome.

Authors:  R L Geggel; K Gauvreau; J E Lock
Journal:  Circulation       Date:  2001-05-01       Impact factor: 29.690

6.  Frequency and risk of in-stent stenosis following pulmonary artery stenting.

Authors:  Anna Hallbergson; James E Lock; Audrey C Marshall
Journal:  Am J Cardiol       Date:  2013-11-08       Impact factor: 2.778

7.  Generalized arteriopathy in Williams syndrome: an intravascular ultrasound study.

Authors:  A J Rein; T J Preminger; S B Perry; J E Lock; S P Sanders
Journal:  J Am Coll Cardiol       Date:  1993-06       Impact factor: 24.094

8.  Cardiovascular abnormalities, interventions, and long-term outcomes in infantile Williams syndrome.

Authors:  R Thomas Collins; Paige Kaplan; Grant W Somes; Jonathan J Rome
Journal:  J Pediatr       Date:  2009-10-21       Impact factor: 4.406

9.  Rapamycin-eluting stents in the arterial duct: experimental observations in the pig model.

Authors:  Kyong-Jin Lee; Aleksander Hinek; Rajiv R Chaturvedi; Claudia L Almeida; Osami Honjo; Gideon Koren; Leland N Benson
Journal:  Circulation       Date:  2009-04-06       Impact factor: 29.690

10.  Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial.

Authors:  Gunnar Tepe; John Laird; Peter Schneider; Marianne Brodmann; Prakash Krishnan; Antonio Micari; Christopher Metzger; Dierk Scheinert; Thomas Zeller; David J Cohen; David B Snead; Beaux Alexander; Mario Landini; Michael R Jaff
Journal:  Circulation       Date:  2014-12-03       Impact factor: 29.690

View more
  1 in total

Review 1.  Williams syndrome.

Authors:  Beth A Kozel; Boaz Barak; Chong Ae Kim; Carolyn B Mervis; Lucy R Osborne; Melanie Porter; Barbara R Pober
Journal:  Nat Rev Dis Primers       Date:  2021-06-17       Impact factor: 65.038

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.